HEPION PHARMACEUTICALS, INC. Preferred Stock, Par or Stated Value Per Share
HEPION PHARMACEUTICALS, INC. (HEPA) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2014-11-13
- 2014-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2014-06-30: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Par or Stated Value Per Share as first filed $0.00.
- 2014-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2013-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Par or Stated Value Per Share as first filed |
|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-K · filed 2014-09-29 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-05 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $0.00 10-K · filed 2014-09-29 | $0.00 10-Q · filed 2013-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |